Skip to main content
Erschienen in: Current Diabetes Reports 7/2019

01.07.2019 | Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors

verfasst von: Ram Jagannathan, Shivani A. Patel, Mohammed K. Ali, K. M. Venkat Narayan

Erschienen in: Current Diabetes Reports | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The last 2–3 decades have witnessed a decline in age-standardized cardiovascular mortality rates in high-income regions, whereas this has only slightly decreased or even increased in most of the low- and middle-income countries. A systematic comparison of global CVD mortality by regions attributable to various modifiable risk factors such as diabetes, obesity, hypertension, poor diet, and physical inactivity is not available.

Recent Findings

We present a summary of time trends and heterogeneity in the distribution of global CVD mortality and the attribution of risk factors between 1990 and 2017 using the Global Burden of Disease (GBD) 2017 study. Globally, an estimated ~ 17.8 million (233.1 per 100,000) people died of CVD in 2017. The rate of CVD death was decreased in high-income countries (1990: 271.8 (95% UI (uncertainty interval), 270.9–273.5); 2017: 128.5 (95% UI, 126.4–130.7) per 100,000)) whereas it remained the same in lower- and middle-income countries (1990: 368.2 (95% UI, 335.6–383.3); 2017: 316.9 (95% UI, 307.0–325.5) per 100,000). Among the various traditional risk factors, high systolic blood pressure, unhealthy diet, high fasting plasma glucose, and high low-density lipoprotein levels were attributed to most of the CVD death and disability-adjusted life year lost. We also observed gender variations in tobacco and increased alcohol consumption. In addition to the traditional risk factors, poor air quality is associated with increased CVD burden in developing countries.

Summary

Surveillance, country-specific guidelines, evidence-based policies, reinforcement of multisectoral health systems, and innovative solutions are urgently needed in resource-challenged settings to curb CVD risk factors and overall burden.
Literatur
2.
Zurück zum Zitat •• James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990&2013;2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. https://doi.org/10.1016/S0140-6736(18)32279-7. Provides comprehensive updates on global disease trends.CrossRef •• James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990&2013;2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. https://​doi.​org/​10.​1016/​S0140-6736(18)32279-7. Provides comprehensive updates on global disease trends.CrossRef
4.
Zurück zum Zitat GBD 2016 DALYs, HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260–344. https://doi.org/10.1016/S0140-6736(17)32130-X.CrossRef GBD 2016 DALYs, HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260–344. https://​doi.​org/​10.​1016/​S0140-6736(17)32130-X.CrossRef
5.
Zurück zum Zitat GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345–422. https://doi.org/10.1016/S0140-6736(17)32366-8.CrossRef GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345–422. https://​doi.​org/​10.​1016/​S0140-6736(17)32366-8.CrossRef
8.
Zurück zum Zitat • NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet (London, England). 2016;387(10027):1513–30. https://doi.org/10.1016/S0140-6736(16)00618-8. Provides comprehensive updates on global diabetes disease trends.CrossRef • NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet (London, England). 2016;387(10027):1513–30. https://​doi.​org/​10.​1016/​S0140-6736(16)00618-8. Provides comprehensive updates on global diabetes disease trends.CrossRef
10.
Zurück zum Zitat Siu AL, U S Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(11):861–8.CrossRef Siu AL, U S Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(11):861–8.CrossRef
14.
Zurück zum Zitat Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials. A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the. American Heart Association. 2009;32(1):187–92. https://doi.org/10.2337/dc08-9026%JDiabetesCare. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials. A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the. American Heart Association. 2009;32(1):187–92. https://​doi.​org/​10.​2337/​dc08-9026%JDiabetesCare.
16.
Zurück zum Zitat Ali MK, Singh K, Kondal D, Devarajan R, Patel SA, Shivashankar R, et al. Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals: a randomized, controlled trial multicomponent quality improvement strategy to improve diabetes care goals. Ann Int Med. 2016;165(6):399–408. https://doi.org/10.7326/M15-2807.CrossRefPubMed Ali MK, Singh K, Kondal D, Devarajan R, Patel SA, Shivashankar R, et al. Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals: a randomized, controlled trial multicomponent quality improvement strategy to improve diabetes care goals. Ann Int Med. 2016;165(6):399–408. https://​doi.​org/​10.​7326/​M15-2807.CrossRefPubMed
24.
Zurück zum Zitat Neupane D, McLachlan CS, Mishra SR, Olsen MH, Perry HB, Karki A, et al. Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial. Lancet Glob Health. 2018;6(1):e66–73.CrossRef Neupane D, McLachlan CS, Mishra SR, Olsen MH, Perry HB, Karki A, et al. Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial. Lancet Glob Health. 2018;6(1):e66–73.CrossRef
33.
Zurück zum Zitat Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012;380(9859):2224–60. https://doi.org/10.1016/s0140-6736(12)61766-8.CrossRefPubMedCentral Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012;380(9859):2224–60. https://​doi.​org/​10.​1016/​s0140-6736(12)61766-8.CrossRefPubMedCentral
42.
Zurück zum Zitat Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2013;1(3):191–8.CrossRef Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2013;1(3):191–8.CrossRef
47.
48.
Zurück zum Zitat • Ali MK, Jaacks LM, Kowalski AJ, Siegel KR, Ezzati M. Noncommunicable diseases: three decades of global data show a mixture of increases and decreases in mortality rates. Health affairs (Project Hope). 2015;34(9):1444–55. https://doi.org/10.1377/hlthaff.2015.0570. Trends in mortality rates caused by non-communicable diseases from 49 countries.CrossRef • Ali MK, Jaacks LM, Kowalski AJ, Siegel KR, Ezzati M. Noncommunicable diseases: three decades of global data show a mixture of increases and decreases in mortality rates. Health affairs (Project Hope). 2015;34(9):1444–55. https://​doi.​org/​10.​1377/​hlthaff.​2015.​0570. Trends in mortality rates caused by non-communicable diseases from 49 countries.CrossRef
51.
Zurück zum Zitat Al-Nsour M, Zindah M, Belbeisi A, Hadaddin R, Brown DW, Walke H. Prevalence of selected chronic, noncommunicable disease risk factors in Jordan: results of the 2007 Jordan Behavioral Risk Factor Surveillance Survey. Prev Chronic Dis. 2012;9:E25.PubMed Al-Nsour M, Zindah M, Belbeisi A, Hadaddin R, Brown DW, Walke H. Prevalence of selected chronic, noncommunicable disease risk factors in Jordan: results of the 2007 Jordan Behavioral Risk Factor Surveillance Survey. Prev Chronic Dis. 2012;9:E25.PubMed
53.
Zurück zum Zitat Reed GJMR. New survey results enhance Cuba’s NCD surveillance: Mariano Bonet, MD. Director, National Hygiene. Epidemiol Microbiol Inst. 2011;13(4):11–3. Reed GJMR. New survey results enhance Cuba’s NCD surveillance: Mariano Bonet, MD. Director, National Hygiene. Epidemiol Microbiol Inst. 2011;13(4):11–3.
54.
Zurück zum Zitat Choi BC, Corber SJ, McQueen DV, Bonita R, Zevallos JC, Douglas KA, et al. Enhancing regional capacity in chronic disease surveillance in the Americas. Rev Panam Salud Publica. 2005;17:130–41.CrossRef Choi BC, Corber SJ, McQueen DV, Bonita R, Zevallos JC, Douglas KA, et al. Enhancing regional capacity in chronic disease surveillance in the Americas. Rev Panam Salud Publica. 2005;17:130–41.CrossRef
55.
Zurück zum Zitat Raccah D, Chou E, Colagiuri S, Gaal Z, Lavalle F, Mkrtumyan A, et al. A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin. Diabetes Metab Res Rev. 2017;33(3):e2858. https://doi.org/10.1002/dmrr.2858.CrossRef Raccah D, Chou E, Colagiuri S, Gaal Z, Lavalle F, Mkrtumyan A, et al. A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin. Diabetes Metab Res Rev. 2017;33(3):e2858. https://​doi.​org/​10.​1002/​dmrr.​2858.CrossRef
56.
Zurück zum Zitat Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–68.CrossRef Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–68.CrossRef
58.
Zurück zum Zitat Teo K, Lear S, Islam S, Mony P, Dehghan M, Li W, et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle-and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study. JAMA. 2013;309(15):1613–21.CrossRef Teo K, Lear S, Islam S, Mony P, Dehghan M, Li W, et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle-and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study. JAMA. 2013;309(15):1613–21.CrossRef
66.
Zurück zum Zitat Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in US adults? Diabetes Care. 2008;31(1):81–6.CrossRef Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in US adults? Diabetes Care. 2008;31(1):81–6.CrossRef
Metadaten
Titel
Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors
verfasst von
Ram Jagannathan
Shivani A. Patel
Mohammed K. Ali
K. M. Venkat Narayan
Publikationsdatum
01.07.2019
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 7/2019
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-019-1161-2

Weitere Artikel der Ausgabe 7/2019

Current Diabetes Reports 7/2019 Zur Ausgabe

Microvascular Complications—Nephropathy (M Afkarian and B Roshanravan, Section Editors)

Circadian Clock Genes in Diabetic Kidney Disease (DKD)

Microvascular Complications—Nephropathy (M Afkarian and B Roshanravan, Section Editors)

Physical Activity in the Prevention of Development and Progression of Kidney Disease in Type 1 Diabetes

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Assessment of Heart Failure in Diabetes Cardiovascular Outcomes Trials: Is What We Are Currently Capturing Adequate?

Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors)

Diabetes Prevention Programs in Rural North America: a Systematic Scoping Review

Pathogenesis of Type 2 Diabetes and Insulin Resistance (M-E Patti, Section Editor)

Paternal Nongenetic Intergenerational Transmission of Metabolic Disease Risk

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.